Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Urology · Benign Prostatic Hyperplasia

Navigating the Diagnostic Process

At a Glance

Doctors diagnose BPH by combining urinary symptoms and medical history with an examination, urinalysis, and selected tests such as PSA, urine-flow measurement, residual urine checks, ultrasound, cystoscopy, or urodynamics. No single test proves that prostate enlargement is causing obstruction.

Diagnosing Benign Prostatic Hyperplasia (BPH) is a process of evaluating your symptoms and ruling out other causes. Because urinary symptoms can originate in the bladder, the kidneys, or even from medications, your clinician will follow a structured evaluation to determine if prostate enlargement is causing an obstruction [1][2].

The Baseline Evaluation

The first step in your diagnostic journey involves a baseline assessment. This set of tests is generally recommended to rule out other conditions and measure how much your symptoms are affecting your life.

  • Medical History and Symptom Score: Your clinician will ask about your health history (including medications and past surgeries) and typically have you complete the International Prostate Symptom Score (IPSS). This questionnaire quantifies your symptoms and helps track whether treatments are working over time [3][4].
  • Physical Examination: This includes a Digital Rectal Exam (DRE). By inserting a gloved, lubricated finger into the rectum, your doctor can estimate the size of the prostate and check for hard areas. However, DRE gives only a rough estimate of size, and it cannot definitively rule cancer in or out; abnormal findings usually prompt separate risk-based testing [2][5].
  • Urinalysis: A simple urine test is usually recommended for every patient as part of the initial evaluation to rule out urinary tract infections (UTIs) or microscopic blood in the urine [2][4].
  • PSA Blood Test: The Prostate-Specific Antigen (PSA) test is a shared, individualized decision. It is helpful if detecting prostate cancer would alter your management, and it can help estimate the risk of your BPH progressing. However, PSA is not cancer-specific—it can be elevated by large prostate size, infections, or certain medications [4][6].

Functional Testing: Measuring the Flow

Your doctor may perform initial tests to see how your urinary system is functioning. While these tests show if there is an issue, they cannot alone confirm that BPH is the specific cause.

  • Uroflowmetry: You will be asked to urinate into a special funnel that measures the speed and volume of your stream. A slow flow can reflect an obstruction, but it can also be caused by a weak bladder muscle [4][7].
  • Post-Void Residual (PVR): After you urinate, an ultrasound or a small catheter is used to see how much urine remains in your bladder. There is no single universal “danger” threshold for PVR. A high residual volume is a reason for further evaluation—it may reflect obstruction, bladder underactivity, or both—rather than an automatic indication for surgery [2][8].

Imaging: Seeing the Prostate

Ultrasound is a tool used to characterize the anatomy of your prostate.

  • Prostate Volume: Ultrasound can accurately measure the size of the prostate [2].
  • Intravesical Prostatic Protrusion (IPP): This identifies if the prostate is growing upward into the bladder, which can create a “ball-valve” obstruction [2][9].
  • Upper Tract Imaging: If you have specific red flags, such as blood in your urine, your doctor may use ultrasound or a CT scan to check your kidneys for signs of pressure or other causes [4]. Note that visible hematuria often requires a direct look into the bladder (cystoscopy) and upper-tract imaging to thoroughly evaluate for cancer or stones.

Advanced Tests: For Uncertain Diagnoses or Planning Surgery

Advanced tests are not routinely necessary for everyone. They are selected when the diagnosis is uncertain, if initial treatments fail, or to plan a surgical procedure.

  • Pressure-Flow Studies (Urodynamics): This test involves placing small sensors in the bladder to measure the pressure the bladder muscle generates while you urinate. It is the best way to distinguish between a blocked prostate (obstruction) and a weak bladder muscle (detrusor underactivity) [10][8].
  • Cystoscopy: A clinician uses a thin, lighted tube with a camera to look inside the urethra and bladder. This is utilized if a narrowing (stricture) is suspected in the urethra, to evaluate blood in the urine, or to examine the shape of the prostate prior to surgery [2][11].

Common questions in this guide

What tests are used to diagnose benign prostatic hyperplasia?
Clinicians usually begin with your medical history, an International Prostate Symptom Score questionnaire, a physical examination, and urinalysis. Depending on your symptoms and goals, they may add a PSA blood test, urine-flow testing, a post-void residual measurement, or ultrasound. More invasive tests are reserved for selected situations.
What does a high post-void residual mean?
A high post-void residual means that urine remains in your bladder after you urinate. It can result from blockage, a bladder muscle that does not contract strongly, or both, so there is no single universal number that automatically means surgery is needed. Your clinician uses the result with your symptoms and other tests to decide whether further evaluation is needed.
Can a slow urine stream prove that BPH is causing my symptoms?
No. Uroflowmetry can show that urine is moving slowly, but a weak bladder muscle can cause the same finding. If the cause is uncertain, a pressure-flow study can help distinguish prostate obstruction from reduced bladder muscle strength.
What does a PSA test tell me if I have an enlarged prostate?
PSA is not specific for prostate cancer or BPH. A larger prostate, infection, and some medicines can raise the result, so your clinician interprets it with your age, prostate findings, symptoms, and goals. PSA testing is an individualized decision, especially when finding prostate cancer would change management.
When might I need cystoscopy or urodynamic testing for BPH?
These tests are not routinely needed for everyone. Cystoscopy may be used when a urethral narrowing or blood in the urine is suspected, or to examine the prostate before surgery; urodynamics may be considered when the diagnosis is uncertain or treatment has not helped. They provide different information about the urethra, bladder, and how well the bladder muscle generates pressure during urination.
Can a digital rectal exam confirm BPH or rule out prostate cancer?
A digital rectal exam can help estimate prostate size and identify hard or unusual areas, but it provides only a rough size estimate. It cannot by itself confirm BPH or rule prostate cancer in or out, so abnormal findings may lead to separate risk-based testing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my International Prostate Symptom Score (IPSS), and does it suggest my symptoms are mild, moderate, or severe?
  2. 2.My post-void residual (PVR) was [insert number] mL—what does this number mean in the context of my bladder health?
  3. 3.Since uroflowmetry shows a slow stream but can't prove my prostate is the cause, what other factors are you considering?
  4. 4.How should we interpret my PSA test results considering my prostate size and age?
  5. 5.If we decide on surgery later, will I need a 'pressure-flow study' or a cystoscopy beforehand to evaluate my bladder?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.

    DeLay KJ, McVary KT

    The Urologic clinics of North America 2016; (43(3)):371-5.

    PMID: 27476129
  2. 2

    [Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].

    Oelke M, Abt SD, Becher KF, et al.

    Urologie (Heidelberg, Germany) 2023; (62(8)):805-817 doi:10.1007/s00120-023-02142-0.

    PMID: 37401972
  3. 3

    How Would You Manage This Patient With Benign Prostatic Hyperplasia? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

    Smetana GW, Smith CC, Singla A, Libman H

    Annals of internal medicine 2023; (176(4)):545-555 doi:10.7326/M23-0113.

    PMID: 37037036
  4. 4

    EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.

    Gratzke C, Bachmann A, Descazeaud A, et al.

    European urology 2015; (67(6)):1099-1109 doi:10.1016/j.eururo.2014.12.038.

    PMID: 25613154
  5. 5

    Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.

    Homma Y, Gotoh M, Kawauchi A, et al.

    International journal of urology : official journal of the Japanese Urological Association 2017; (24(10)):716-729 doi:10.1111/iju.13401.

    PMID: 28748576
  6. 6

    Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

    Gudmundsson J, Sigurdsson JK, Stefansdottir L, et al.

    Nature communications 2018; (9(1)):4568 doi:10.1038/s41467-018-06920-9.

    PMID: 30410027
  7. 7

    Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review.

    Vredeveld T, van Benten E, Beekmans REPM, et al.

    BMJ open 2022; (12(4)):e056234 doi:10.1136/bmjopen-2021-056234.

    PMID: 35487713
  8. 8

    Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.

    Baboudjian M, Hashim H, Bhatt N, et al.

    European urology 2024; (86(3)):213-220 doi:10.1016/j.eururo.2024.04.004.

    PMID: 38644139
  9. 9

    Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms.

    Wang D, Huang H, Law YM, Foo KT

    Annals of the Academy of Medicine, Singapore 2015; (44(2)):60-5.

    PMID: 25797818
  10. 10

    Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence.

    Jiang YH, Kuo HC

    Tzu chi medical journal 2017; (29(2)):72-78 doi:10.4103/tcmj.tcmj_19_17.

    PMID: 28757770
  11. 11

    Pre-therapeutical assessment of lower urinary tract symptoms in adult men: Systematic review and clinical practice guidelines.

    Lebdai S, Doizi S, Kassab D, et al.

    The French journal of urology 2025; (35(3)):102846 doi:10.1016/j.fjurol.2024.102846.

    PMID: 39647566

This page is for informational purposes only and does not constitute medical advice. Your clinician should interpret your BPH symptoms and test results in the context of your health.

Get notified when new evidence is published on prostatic adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.